Navigation Links
Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
Date:11/16/2009

oses them to syncope; are treated concomitantly with antihypertensives or other drugs that can reduce blood pressure or heart rate or increase the risk of syncope. Heart rate and blood pressure should be measured prior to initiation of therapy, following dose increases, and periodically while on therapy. Patients should be advised to avoid becoming dehydrated or overheated.

Sedation and somnolence were commonly observed in clinical trials. The potential for additive sedative effects with CNS depressant drugs should be considered. Patients should be cautioned against operating heavy equipment or driving until they know how they respond to INTUNIV. Avoid use with alcohol.

Common adverse reactions in patients taking INTUNIV that may be dose related over the range of 1 to 4 mg/day include somnolence, sedation, abdominal pain, dizziness, hypotension/decreased blood pressure, dry mouth, and constipation.

About ADHD

ADHD is one of the most common psychiatric disorders in children and adolescents. Worldwide prevalence of ADHD is estimated at 5.3 percent (with large variability), according to a comprehensive systematic review of this topic published in 2007 in the American Journal of Psychiatry. In the United States, approximately 7.8 percent of all school-aged children, or about 4.4 million children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the Centers for Disease Control and Prevention (CDC).

ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. The specific etiology of ADHD is unknown and there is no single diagnostic test for this disorder. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources, utilizing
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... coil is used to treat an unruptured and ... artery wall). The treatment is either known as ... procedure, the endovascular coil blocks the blood flow ... usually performed under general anaesthesia by an interventional ...
(Date:9/2/2015)... 2015 Advanced Wound Dressings - 5EU ... dressings have steadily replaced traditional bandages and gauze ... wound indications, such as trauma wounds, burns, and ... physical protection become increasingly critical in wound healing, ... therapy. This report focuses on nine market ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015   ... of the most common laboratory technologies that is used ... and antibodies in solution. ELISA test uses various types ... alkaline phosphatases and the result is detected by photometry ... in the treatment of various infectious diseases such as ...
Breaking Medicine Technology:Global Neuroendovascular Coil Market 2015-2019 2Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3
... May 3, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... 2011. For the first quarter of 2011, Rigel reported ... to a net loss of $22.3 million, or $0.43 per share, ... the first quarter of 2011 and 2010 were 52.3 million and ...
... Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical ... today announced dosing of the first patient in a ... cenderitide.  The trial is being conducted pursuant to Nile,s ... clinical step towards developing cenderitide as a treatment for ...
Cached Medicine Technology:Rigel Announces First Quarter Financial Results 2Rigel Announces First Quarter Financial Results 3Rigel Announces First Quarter Financial Results 4Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 2Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 3
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... their team will be participating at the highly anticipated Mississippi Gulf Babypalooza on ... mothers coming from all over, from Gulfport, Biloxi, and beyond. We will be ...
(Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have ... of two categories: those that have a weak appetite or those that have a fast ... to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The ...
(Date:9/3/2015)... ... ... Earl Jones will be hosting an upcoming VOICES IN AMERICA segment that highlights the ... that discusses why it is important for the workplace to be healthier, the effects ... environment. , Employers are out billions of dollars year after year due to sick ...
(Date:9/3/2015)... ... 2015 , ... The partnership will leverage Fidson’s strong and ... to promote LodonalTM in Nigeria. The distribution will become effective, upon completion of ... the product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis Ayebae, expressed that ...
(Date:9/2/2015)... ... September 03, 2015 , ... ... listed among the most influential leaders in healthcare, will offer the keynote address ... take place October 15-16, 2015, in Palm Harbor, Florida, at the Innisbrook Resort ...
Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3
... ... information on sexual health and sexual medicine easily accessible to the public and to ... TWSHF board of directors voted to dissolve the non-profit and donate its assets to ... ...
... , , , ... scientist M. Elizabeth "Betz" Halloran, M.D., M.P.H., D.S.c., has been awarded ... honor bestowed upon members of the American Association for the Advancement ... researcher in the Hutchinson Center,s Vaccine and Infectious Disease Institute and ...
... , LOS ANGELES, Dec. 17 ... and Energy-X lip balms, today announced the launch of ... heating/cooling treatment packs are specifically designed to reduce swelling ... variety of applications. Researchers behind Thermal-Aid created a line ...
... , Charmaine Yoest Urges "Comprehensive Respect for Life" in ... , WASHINGTON, Dec. 17 Americans United for Life Action President, ... Harry Reid as he considers a manager,s amendment - the Majority ... bill. The letter urges Senator Reid to include "specific language that ...
... from physician, study finds , THURSDAY, Dec. 17 (HealthDay News) ... parents to place infants on their backs to go to ... SIDS, researchers have found. , Since the U.S. government launched ... infants placed on their backs at sleep time has increased ...
... fall down on prevention, experts say , THURSDAY, Dec. ... getting better at treating heart attacks and other cardiovascular ... for preventing them, according to new statistics from the ... exercise, too much weight. , In fact, 59 percent ...
Cached Medicine News:Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 2Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 3Health News:M. Elizabeth Halloran Named AAAS Fellow 2Health News:M. Elizabeth Halloran Named AAAS Fellow 3Health News:M. Elizabeth Halloran Named AAAS Fellow 4Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3
The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Severe revision options for the knee and hip...
Medicine Products: